Thyroid Disorders as Cardio-Vascular Risks - Seminar 31/05/2024

[helvella]

Join our webinar on 31 May and learn more about thyroid disorders as cardiovascular risks.

Register here:

shorturl.at/2he9v

Speaker: Prof. Leilani B. Mercado-Asis, Endocrinologist University of Santo Tomas, Manila

May 31, 2024

3 pm CEST, Paris time

9:00 am, New York time

AND

Thyroid Disorders as Cardio-Vascular Risks

Date & Time

May 31, 2024 02:00 PM in

Description

Prof. Leilani B. Mercado-Asis, MD, PhD, MPH, MEd (DE)

Professor of Endocrinology in the University of Santo Tomas in Manila; President of the Philippine Society of Hypertension; officer of the World Hypertension League

You can register as any of:

Nurse

Doctor

Medial Professional

Patient

[jimh111]

Thanks, should be interesting. A couple of years ago I posted about cardiac risks of high normal fT4. I need to revise this subject!

Forgot to add the link healthunlocked.com/thyroidu... .

[arTistapple]

Very timely. I hope I learn something useful. I just hope to heck I can set it up. Miracles might happen. Thanks for this helvella, I feel it’s specially for me!

[helvella Administrator in reply to arTistapple]

I hope anyone who "attends" lets us know of anything interesting!

jimh111

[arTistapple in reply to helvella]

If I actually manage to get clued in, I will report back on my ‘hearings’.

[jimh111 in reply to helvella]

I plan to watch. I'm hoping to revise beforehand but I'm leaving it a little late.

[arTistapple]

OK helvella I listened to the webinar. Lots of biochemistry involved. Extremely interesting for anyone with heart issues. Although very useful re: Co-morbidities and relations to said Co-morbidities too. A really good explanation.

A good example (it seemed to me from the biochemical explanation) is that GPs and others should understand that in the case of thyroid - patients who develop Type 2 diabetes, it because they are hypothyroid. It’s an issue of metabolism. Basically it’s an indication that their hypo treatment is not optimal and therefore does not prevent the inevitable - cardiac issues! This is why the arteries fur up. All those nonsense (and time wasting chats) from medical staff making us feel doubly wrong about what we are doing to ourselves!

It’s the hypothyroidism, STUPID! My words

Hypo talked about equally to start but kind of faltered a bit nearer the end because of more emphasis on hyper and proper thyroid medication bringing about excellent results. Of course heart issues do seem to be more overtly common in hyper but they do occur for hypo, that itself was made very clear!

Very emphatic about Subclinical being treated re: heart issues, right from the start. Implied no waiting. This is completely at odds with what happens on the ground here in the UK. No good to me after 20+ years of whining. Aye!

Lots of talk about T3 in ALL process involved. It’s a metabolism issue. No implication that it’s the patients ‘fault’ unlike here in the UK. Very matter of fact. However ‘treatment’ specifics were not discussed.

I wish hypo had been covered a bit more. Very interesting and no doubt something else for me to pore over.

Great you highlighted it. Thank you